UK Markets open in 3 mins

Medtronic plc (MDT)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
112.27+4.99 (+4.65%)
At close: 04:00PM EST
112.89 +0.62 (+0.55%)
After hours: 07:53PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.81
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3135.89
52-week low 3105.02
50-day moving average 3120.18
200-day moving average 3124.38

Share statistics

Avg vol (3-month) 35.14M
Avg vol (10-day) 38.04M
Shares outstanding 51.35B
Implied shares outstanding 6N/A
Float 81.34B
% held by insiders 10.23%
% held by institutions 183.22%
Shares short (30 Aug 2021) 410.62M
Short ratio (30 Aug 2021) 42.58
Short % of float (30 Aug 2021) 40.79%
Short % of shares outstanding (30 Aug 2021) 40.79%
Shares short (prior month 29 Jul 2021) 411.1M

Dividends & splits

Forward annual dividend rate 42.52
Forward annual dividend yield 41.94%
Trailing annual dividend rate 32.32
Trailing annual dividend yield 32.16%
5-year average dividend yield 42.08
Payout ratio 482.87%
Dividend date 314 Oct 2021
Ex-dividend date 422 Sept 2021
Last split factor 22:1
Last split date 326 Sept 1999

Financial highlights

Fiscal year

Fiscal year ends 29 Apr 2021
Most-recent quarter (mrq)29 Jul 2021

Profitability

Profit margin 12.29%
Operating margin (ttm)20.42%

Management effectiveness

Return on assets (ttm)4.34%
Return on equity (ttm)7.65%

Income statement

Revenue (ttm)31.6B
Revenue per share (ttm)23.48
Quarterly revenue growth (yoy)22.70%
Gross profit (ttm)19.76B
EBITDA 9.16B
Net income avi to common (ttm)3.88B
Diluted EPS (ttm)2.66
Quarterly earnings growth (yoy)56.70%

Balance sheet

Total cash (mrq)10.6B
Total cash per share (mrq)7.87
Total debt (mrq)25.96B
Total debt/equity (mrq)50.26
Current ratio (mrq)2.89
Book value per share (mrq)38.22

Cash flow statement

Operating cash flow (ttm)7.25B
Levered free cash flow (ttm)5.28B